Fenofibrate causes regression of endometriotic implants: a rat model  

Oleh:

Onalan, Gogsen ; Zeyneloglu, Hulusi B. ; Bayraktar, Nilufer

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Fertility and Sterility (keterangan: ada di ClinicalKey) vol. 92 no. 06 (Dec. 2009), page 2100-2102.
Topik: Endometriosis; rat; fenofibrate; angiogenesis; treatment

Ketersediaan

Perpustakaan FK Nomor Panggil: F02.K.2009.04 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Fenofibrate -a peroxisome proliferator-activated receptor-a agonist- is an angiostatic agent that is commonly used in human liver diseases, therefore it may interfere with the angiogenetic process required for endometriosis. In a rat endometriosis model, we demonstrated that peritoneal implant areas and vascular endothelial growth factor levels in the peritoneal flud were significantly decreased in high dose or low dose finofibrate and luprolide acetate treated groups compared to control.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali